Hong Kong Pharmaceuticals & Biotech Mid-Large Cap Stocks

Sino Biopharmaceutical

Market Cap: HK$88.7b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Consun Pharmaceutical Group

Market Cap: HK$11.4b

Produces and sells pharmaceutical products in Mainland China.

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.1b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$92.6b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$29.6b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

United Laboratories International Holdings

Market Cap: HK$18.1b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

China Medical System Holdings

Market Cap: HK$29.5b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Simcere Pharmaceutical Group

Market Cap: HK$32.4b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

Grand Pharmaceutical Group

Market Cap: HK$18.1b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Ab&B Bio-Tech JS

Market Cap: HK$11.5b

Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.

Ascentage Pharma Group International

Market Cap: HK$13.2b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$116.3b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

HBM Holdings

Market Cap: HK$10.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

XtalPi Holdings

Market Cap: HK$30.9b

Operates as a research platform company in Mainland China, the United States, and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$51.1b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Shaanxi Micot Pharmaceutical Technology

Market Cap: HK$13.4b

Shaanxi Micot Pharmaceutical Technology Co., Ltd.

CARsgen Therapeutics Holdings

Market Cap: HK$9.5b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

3SBio

Market Cap: HK$40.3b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Shanghai Junshi Biosciences

Market Cap: HK$35.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.

Innovent Biologics

Market Cap: HK$154.9b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Metis TechBio

Market Cap: HK$11.7b

Engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States.

Shanghai Henlius Biotech

Market Cap: HK$31.4b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

Lepu Biopharma

Market Cap: HK$8.1b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally.

RemeGen

Market Cap: HK$63.3b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

Luye Pharma Group

Market Cap: HK$8.2b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

Hansoh Pharmaceutical Group

Market Cap: HK$192.8b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Sunshine Lake Pharma

Market Cap: HK$16.1b

Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

Duality Biotherapeutics

Market Cap: HK$19.4b

A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others in China and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$151.8b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.

Alebund Pharmaceuticals (Jiangsu)

Market Cap: HK$9.5b

Operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China and Hong Kong.

Everest Medicines

Market Cap: HK$8.7b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

Fujian Haixi Pharmaceuticals

Market Cap: HK$14.7b

Engages in research and development, production, and sale of pharmaceutical products in China.

Vigonvita Life Sciences

Market Cap: HK$9.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas.

Akeso

Market Cap: HK$81.4b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Ascletis Pharma

Market Cap: HK$8.9b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

Genscript Biotech

Market Cap: HK$28.9b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.